Trial intelligence / Profile preview

Pregabalin for Cancer-Induced Bone Pain (Randomized Placebo-Controlled)

2006-002486-39Phase 4Terminated

Sponsor
Pfizer
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in bone metastases and bone metastasis pain (CIBP) comparing Pregabalin + opioids with Placebo + opioids (2 arms). Primary endpoint: Change in worst pain score at reference site. Started Sep 2006; status: terminated.

02

Drugs

pregabalin
03

Conditions

bone metastasesbone metastasis pain (CIBP)

Beyond the preview

Go deeper on 2006-002486-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002486-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call